WAVE Life Sciences Ltd diskutieren
WAVE Life Sciences Ltd
WKN: A1436W / Symbol: WVE / Name: WAVE Life / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
?
-7,28 %
WAVE Life Sciences (NASDAQ:WVE) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its price target lowered by analysts at Wells Fargo & Company from $18.00 to $16.00. They now have an "overweight" rating on the stock.
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Wedbush from $18.00 to $20.00. They now have an "outperform" rating on the stock.
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Cantor Fitzgerald from $12.00 to $34.00. They now have an "overweight" rating on the stock.
Ratings data for WVE provided by MarketBeat


Neueste Beiträge
Cowen_Inc in Rhythm Pharmaceuticals diskutieren